Acies Acquisition Corp. (ACAC) Shareholders Approve PLAYSTUDIOS Deal
by Marlena Haddad on 2021-06-17 at 1:50pm

Acies Acquisition Corp. (NASDAQ:ACAC) announced in a press release that its shareholders approved its combination with social gaming developer PLAYSTUDIOS, Inc. at a special meeting earlier today.

The press release did not mention redemption amounts, but it notes that approximately 97% of the votes cast at the special meeting approved of the business combination.  The transaction is expected to close as soon as practicable, and the combined entity’s shares and warrants will start trading on the Nasdaq under the symbols, “MYPS” and “MYPSW”, respectively.

PLAYSTUDIOS started 2021 off strong with 27% growth in revenue, but ACAC dropped 2% to $9.63 following the meeting.

The parties initially announced the $1.1 billion deal on February 2. Las Vegas-based PLAYSTUDIOS develops casual free-to-play games that grant players real world benefits at client businesses in retail, travel and leisure as a gamified loyalty experience.


ADVISORS

  • J.P. Morgan and LionTree Advisors are acting as financial advisors to PLAYSTUDIOS.
  • Davis Polk is acting as legal advisor to the company.
  • Morgan Stanley is acting as capital markets advisor to Acies Acquisition Corp.
  • Latham & Watkins LLP is acting as legal advisor to Acies.
  • J.P. Morgan, LionTree Advisors, Morgan Stanley, and Oppenheimer & Co. are acting as placement agents for the PIPE.
Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved